Log In
Print
BCIQ
Print
Print this Print this
 

SAGE-547

  Manage Alerts
Collapse Summary General Information
Company Sage Therapeutics Inc.
DescriptionPositive allosteric modulator (PAM) of GABA A receptor
Molecular Target GABA A receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSeizures
Indication DetailsTreat refractory status epilepticus (SE); Treat status epilepticus; Treat super-refractory status epilepticus (SRSE)
Regulatory Designation

U.S. - Fast Track (Treat refractory status epilepticus (SE));
U.S. - Orphan Drug (Treat status epilepticus)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today